A carregar...
Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
The incretin system has become an important target in the treatment of type 2 diabetes in recent years, and glucagon-like peptide 1 (GLP-1) is of particular interest for its glucose-lowering effects. The physiological response to oral ingestion of nutrients, involving the incretin system, is reduced...
Na minha lista:
| Publicado no: | Diabetes Spectr |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Diabetes Association
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5556578/ https://ncbi.nlm.nih.gov/pubmed/28848315 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/ds16-0026 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|